Hypolipidemic Agents

Publication Title: 
Complementary Therapies in Medicine

OBJECTIVE: To evaluate the scientific evidence on guggul for hyperlipidemia including expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing. METHODS: Electronic searches were conducted in nine databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on language or quality of publications.

Author(s): 
Ulbricht, Catherine
Basch, Ethan
Szapary, Philippe
Hammerness, Paul
Axentsev, Serguei
Boon, Heather
Kroll, David
Garraway, Levi
Vora, Mamta
Woods, Jen
Natural Standard Research Collaboration
Publication Title: 
Homeopathy: The Journal of the Faculty of Homeopathy

Hahnemann considered the secondary action of medicines to be a law of nature and reviewed the conditions under which it occurs. It is closely related to the rebound effects observed with many modern drugs. I review the evidence of the rebound effect of statins that support the similitude principle. In view of their indications in primary and secondary prevention of cardiovascular diseases, statins are widely prescribed.

Author(s): 
Teixeira, Marcus Zulian
Publication Title: 
International Journal of Cardiology

The effect of orally administered indigenous drugs Terminalia arjuna, T. belerica and T. chebula were investigated on experimental atherosclerosis. Rabbits were fed a cholesterol-rich diet to induce atherosclerosis. The three drugs were fed along with cholesterol. At the end of the experimental period the animals were killed and their plasma and tissue lipid components estimated. Atherosclerotic lesions of the aorta were examined histologically. T. arjuna was found to be the most potent hypolipidemic agent and induced partial inhibition of rabbit atheroma. The results indicate that T.

Author(s): 
Shaila, H. P.
Udupa, S. L.
Udupa, A. L.
Publication Title: 
Pharmaceutical Biology

CONTEXT: Hyperlipidemia is known to be a major risk factor for the development of cardiovascular diseases (CVDs) which include atherosclerosis, coronary heart disease, and stroke. Although there are a large number of anti-hyperlipidemic drugs available, unfortunately, they all have side effects. OBJECTIVE: Terminalia chebula Retz. (Combretaceae) is a plant used to treat cardiac disorders in the traditional Ayurveda medicine in India. The objective of this study was to assess the anti-hyperlipidemic properties of a methanol (MeOH) bark extract of T. chebula.

Author(s): 
Reddy, Murali Mohan
Dhas Devavaram, Jackson
Dhas, Jebasingh
Adeghate, Ernest
Starling Emerald, Bright
Publication Title: 
Biomedicine & Pharmacotherapy = BiomÈdecine & PharmacothÈrapie

Caloric restriction (CR) and a reduced growth hormone (GH)-insulin-like growth factor (IGF-1) axis are associated with an extension of lifespan across taxa. Evidence is reviewed showing that CR and reduced insulin of GH-IGF-1 axis may exhibit their effects at least partly by their common stimulatory action on autophagy, the cell repair mechanism responsible for the housekeeping of cell membranes and organelles including the free radical generators peroxisomes and mitochondria.

Author(s): 
Bergamini, E.
Cavallini, G.
Donati, A.
Gori, Z.
Publication Title: 
Circulation

Human high density lipoprotein (HDL) contains at least two types of lipoprotein-containing A-I particles: one contains both apolipoproteins (apo) A-I and A-II (Lp A-I:A-II) as main protein components, whereas in the other, apo A-II is absent (Lp A-I). The two subpopulations have different metabolisms and physiological roles. Studies indicate that apo A-II is an antagonist of cholesterol efflux. Lp A-I but not Lp A-I:A-II is increased in women compared with men. The lower apo A-I levels in patients with coronary artery disease reflect a decrease in Lp A-I.

Author(s): 
Fruchart, J. C.
Ailhaud, G.
Bard, J. M.
Publication Title: 
Pharmacology & Toxicology

Recent studies in man and human apolipoprotein A-I transgenic animals emphasize the significance of apolipoprotein A-I and high density lipoprotein in antiatherogenesis. Several drugs and other compounds, e.g. phenobarbital, gemfibrozil, fenofibrate, prednisone, estrogen and alcohol, induce apolipoprotein A-I synthesis. They commonly produce serum lipoprotein patterns typical of a low risk of coronary heart disease, and many of them have been found to prevent atherogenesis, reduce coronary heart disease mortality and increase survival.

Author(s): 
Luoma, P. V.
Publication Title: 
Hematology/Oncology Clinics of North America

Statin drugs and various isoprenoids from plant origins inhibit mevalonic acids, cholesterol, and other isoprenoid products. Among these, reduction of farnesyl and geranylgeranyl prenylated proteins impedes signal transduction at the cellular level. The authors envision that limiting such prenylated proteins downregulates thrombin-stimulated events, including decreasing the expression and availability of protease-activated receptor-1 mitigating thrombin stimulation of cells, tissue factor preventing additional thrombin generation, and plasminogen activator inhibitor-1 allowing thrombosis.

Author(s): 
Fenton, J. W.
Shen, G. X.
Minnear, F. L.
Brezniak, D. V.
Jeske, W. P.
Walenga, J. M.
Bognacki, J. J.
Ofosu, F. A.
Hassouna, H. I.
Publication Title: 
The European journal of health economics: HEPAC: health economics in prevention and care

To curb the heavily increasing drug budgets some Danish counties have introduced voluntary agreements between general practitioners (GPs) and health authorities. We extend the models of generic prescription by Hellerstein (Rand J Econ 29(1):108-136, 1998) and Lundin (J Health Econ 19:639-662, 2000) to allow for substitution between analogues and use difference-in-difference models to assess the effect on two drug groups (lipid-lowering and rheumatism drugs). For both drug groups we find evidence of a significant effect of the intervention.

Author(s): 
Olsen, Kim Rose
Gyrd-Hansen, Dorte
Boegh, Andreas
Hansen, Sofie Hartung
Publication Title: 
Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan

Hypercholesteremia is one of the risk factors for coronary artery disease. The present study highlights the efficacy of the ayurvedic herbal formulation Arborium Plus [Hyppophae ramnoides L. fruit juice (S) and Rhododendron arboreum Sm. Linn flower juice (R) in a 1:4 ratio] on triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), atherogenic index (AI), high-density lipoprotein (HDL), and high-sensitivity c-reactive protein (hs CRP) in experimentally induced hypercholesterolemic rabbits.

Author(s): 
Murty, Devarakonda
Rajesh, Enjamoori
Raghava, Doonaboina
Raghavan, Tangaraj Vijaya
Surulivel, Mukanthan Karupiah Munirajan

Pages

Subscribe to RSS - Hypolipidemic Agents